[go: up one dir, main page]

ZA979725B - Benzoaxozole derivative. - Google Patents

Benzoaxozole derivative.

Info

Publication number
ZA979725B
ZA979725B ZA9709725A ZA979725A ZA979725B ZA 979725 B ZA979725 B ZA 979725B ZA 9709725 A ZA9709725 A ZA 9709725A ZA 979725 A ZA979725 A ZA 979725A ZA 979725 B ZA979725 B ZA 979725B
Authority
ZA
South Africa
Prior art keywords
benzoaxozole
derivative
benzoaxozole derivative
Prior art date
Application number
ZA9709725A
Inventor
Helmut Pruecher
Rudolf Gottschlich
Joachim Leibrock
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA979725B publication Critical patent/ZA979725B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9709725A 1996-10-30 1997-10-29 Benzoaxozole derivative. ZA979725B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19643790A DE19643790A1 (en) 1996-10-30 1996-10-30 Benzoxazole derivative

Publications (1)

Publication Number Publication Date
ZA979725B true ZA979725B (en) 1998-05-22

Family

ID=7809592

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709725A ZA979725B (en) 1996-10-30 1997-10-29 Benzoaxozole derivative.

Country Status (16)

Country Link
EP (1) EP0938485A1 (en)
JP (1) JP2001502713A (en)
KR (1) KR20000052876A (en)
CN (1) CN1235604A (en)
AR (1) AR008512A1 (en)
AU (1) AU4946597A (en)
BR (1) BR9712577A (en)
CA (1) CA2270359A1 (en)
CZ (1) CZ147999A3 (en)
DE (1) DE19643790A1 (en)
HU (1) HUP9904547A3 (en)
NO (1) NO992063L (en)
PL (1) PL332771A1 (en)
SK (1) SK53699A3 (en)
WO (1) WO1998018793A1 (en)
ZA (1) ZA979725B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
DE19812331A1 (en) 1998-03-20 1999-09-23 Merck Patent Gmbh New benzo-heterocyclic substituted piperidine derivatives useful as excitatory aminoacid receptor antagonists, used e.g. for treating neurodegenerative diseases
PE20000728A1 (en) 1998-06-26 2000-08-21 Cocensys Inc HETEROCYCLES 4-BENZYL PIPERIDINE ALKYLSULFOXIDE AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS
US6476041B1 (en) * 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
EP1674087A1 (en) 2000-10-02 2006-06-28 Pfizer Products Inc. Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
DE10120159A1 (en) * 2001-04-25 2002-10-31 Merck Patent Gmbh NMDA antagonists and NMDA agonists for the treatment of addictions
ATE408611T1 (en) 2001-07-24 2008-10-15 Richter Gedeon Nyrt PIPERIDINES AS NMDA RECEPTOR ANTAGONISTS
DE102007047737A1 (en) 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidine and piperazine derivatives
DE102009049211A1 (en) 2009-10-13 2011-04-28 Merck Patent Gmbh sulfoxides
AU2012340670B2 (en) 2011-11-22 2016-12-22 The Regents Of The University Of California Cysteamine and/or cystamine for treating ischemic injury

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0709384B1 (en) * 1994-10-31 1998-12-23 MERCK PATENT GmbH Benzylpiperidine derivatives having high affinity for binding sites of aminoacid receptors

Also Published As

Publication number Publication date
KR20000052876A (en) 2000-08-25
HUP9904547A3 (en) 2001-01-29
CZ147999A3 (en) 1999-08-11
AU4946597A (en) 1998-05-22
WO1998018793A1 (en) 1998-05-07
CN1235604A (en) 1999-11-17
NO992063D0 (en) 1999-04-29
DE19643790A1 (en) 1998-05-07
CA2270359A1 (en) 1998-05-07
AR008512A1 (en) 2000-01-19
HUP9904547A2 (en) 2000-12-28
JP2001502713A (en) 2001-02-27
BR9712577A (en) 1999-10-19
NO992063L (en) 1999-04-29
PL332771A1 (en) 1999-10-11
SK53699A3 (en) 2000-03-13
EP0938485A1 (en) 1999-09-01

Similar Documents

Publication Publication Date Title
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA9711092B (en) Novel compounds.
ZA976021B (en) Bicyclic-fused pyridines.
ZA977206B (en) Arylalkanoylpyridazines.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA976224B (en) 4-hydroxy-piperidine derivatives.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA9711567B (en) Compounds.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA975861B (en) Bromotiacumicin compounds.
ZA979725B (en) Benzoaxozole derivative.
ZA982436B (en) Thiazolimine derivatives.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA97928B (en) Novel heteroaryl-oxazolidinones.
ZA974052B (en) New benzothiazolinones.
ZA9710653B (en) 4-hydroxy-piperidine derivatives.
ZA976022B (en) Cycloalkano-pyridines.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA971466B (en) Endothelin-receptor-antagonists.